%0 Journal Article %A Min J. Kong %A Aaron F. Yang %A Sujay A. Vora %A Jeffrey S. Ross %A Ming Yang %T The Complementary Role of 68Ga-DOTATATE PET/CT in Diagnosis of Recurrent Meningioma %D 2022 %R 10.2967/jnmt.122.263949 %J Journal of Nuclear Medicine Technology %P jnmt.122.263949 %X Introduction: Contrast-enhanced brain MRI is the choice of imaging modality in diagnosis and posttreatment evaluation, its role is limited in distinguishing recurrent lesion from postoperative change. 68Ga-DOTATATE is a somatostatin analog PET tracer which has high affinity to meningioma expressing somatostatin receptor. Methods and subjects: In this case series review, we described 8 patients with brain MRI suspected of recurrent meningioma who underwent focused 68Ga-DOTATATE PET/CT scan for radiation treatment planning. Results: The combined brain MRI and PET/CT allowed improved conspicuity of the lesions and aided radiation treatment planning. The time from the initial surgery to PET/CT scans varied widely ranging from 1 year to 12 years. Three patients had PET/CT shortly after the initial surgery (1-3 years) and underwent targeted radiation therapy. Subsequent imaging showed no evidence of recurrence. Four patients had prolonged time between the PET/CT and the initial surgery (7-12 years) which showed extensive tumor burden. All four patients expired shortly after the last PET/CT scan. Conclusion: 68Ga-DOTATATE PET shows promising complementary role in detection and treatment planning of recurrent meningioma. %U https://tech.snmjournals.org/content/jnmt/early/2022/08/30/jnmt.122.263949.full.pdf